Annual Total Liabilities
$5.05 M
+$2.96 M+141.51%
December 1, 2023
Summary
- As of February 10, 2025, NRSN annual total liabilities is $5.05 million, with the most recent change of +$2.96 million (+141.51%) on December 1, 2023.
- During the last 3 years, NRSN annual total liabilities has risen by +$4.93 million (+4108.33%).
- NRSN annual total liabilities is now at all-time high.
Performance
NRSN Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$3.80 M
+$258.00 K+7.28%
September 1, 2024
Summary
- As of February 10, 2025, NRSN quarterly total liabilities is $3.80 million, with the most recent change of +$258.00 thousand (+7.28%) on September 1, 2024.
- Over the past year, NRSN quarterly total liabilities has dropped by -$4.64 million (-54.95%).
- NRSN quarterly total liabilities is now -59.61% below its all-time high of $9.41 million, reached on June 30, 2023.
Performance
NRSN Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
NRSN Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +141.5% | -55.0% |
| 3 y3 years | +4108.3% | +135.1% |
| 5 y5 years | +10000.0% | - |
NRSN Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +141.5% | -59.6% | +174.7% |
| 5 y | 5-year | at high | >+9999.0% | -59.6% | +3068.3% |
| alltime | all time | at high | >+9999.0% | -59.6% | +3068.3% |
NeuroSense Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.80 M(+7.3%) |
| Jun 2024 | - | $3.54 M(-58.0%) |
| Mar 2024 | - | $8.44 M(+67.1%) |
| Dec 2023 | $5.05 M(+141.5%) | $5.05 M(-9.5%) |
| Sep 2023 | - | $5.58 M(-40.7%) |
| Jun 2023 | - | $9.41 M(+284.8%) |
| Mar 2023 | - | $2.45 M(+17.0%) |
| Dec 2022 | $2.09 M | $2.09 M(+51.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $1.38 M(-14.4%) |
| Jun 2022 | - | $1.62 M(-28.2%) |
| Mar 2022 | - | $2.25 M(-7.2%) |
| Dec 2021 | $2.42 M(+1920.8%) | - |
| Dec 2021 | - | $2.42 M(+1840.0%) |
| Jun 2021 | - | $125.00 K(+4.2%) |
| Dec 2020 | $120.00 K(+224.3%) | $120.00 K |
| Dec 2019 | $37.00 K | - |
FAQ
- What is NeuroSense Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for NeuroSense Therapeutics?
- What is NeuroSense Therapeutics annual total liabilities year-on-year change?
- What is NeuroSense Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for NeuroSense Therapeutics?
- What is NeuroSense Therapeutics quarterly total liabilities year-on-year change?
What is NeuroSense Therapeutics annual total liabilities?
The current annual total liabilities of NRSN is $5.05 M
What is the all time high annual total liabilities for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high annual total liabilities is $5.05 M
What is NeuroSense Therapeutics annual total liabilities year-on-year change?
Over the past year, NRSN annual total liabilities has changed by +$2.96 M (+141.51%)
What is NeuroSense Therapeutics quarterly total liabilities?
The current quarterly total liabilities of NRSN is $3.80 M
What is the all time high quarterly total liabilities for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high quarterly total liabilities is $9.41 M
What is NeuroSense Therapeutics quarterly total liabilities year-on-year change?
Over the past year, NRSN quarterly total liabilities has changed by -$4.64 M (-54.95%)